83 related articles for article (PubMed ID: 26826001)
1. Hepatic IGF-1R overexpression combined with the activation of GSK-3β and FOXO3a in the development of liver cirrhosis.
Liu W; Li J; Cai Y; Wu Q; Pan Y; Chen Y; Chen Y; Zheng X; Li W; Zhang X; E C
Life Sci; 2016 Feb; 147():97-102. PubMed ID: 26826001
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
3. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
[TBL] [Abstract][Full Text] [Related]
4. Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.
Nemoto T; Satoh S; Maruta T; Kanai T; Yoshikawa N; Miyazaki S; Yanagita T; Wada A
Neuropharmacology; 2010 Jun; 58(7):1097-108. PubMed ID: 20144629
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Yasuda Y; Shimizu M; Sakai H; Iwasa J; Kubota M; Adachi S; Osawa Y; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2009 Dec; 182(2-3):159-64. PubMed ID: 19646978
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IGF-1 signaling by genistein: modulation of E-cadherin expression and downregulation of β-catenin signaling in hormone refractory PC-3 prostate cancer cells.
Lee J; Ju J; Park S; Hong SJ; Yoon S
Nutr Cancer; 2012; 64(1):153-62. PubMed ID: 22098108
[TBL] [Abstract][Full Text] [Related]
7. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
[TBL] [Abstract][Full Text] [Related]
8. Hastatoside attenuatescarbon tetrachloride-induced liver fibrosis by targeting glycogen synthase kinase-3β.
Du C; Dong J; Wang Q; Xu C; Feng S; Feng R; Lv X; Li J; Zhang L; Huang C; Ma T
Phytomedicine; 2023 Jan; 109():154585. PubMed ID: 36610117
[TBL] [Abstract][Full Text] [Related]
9. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I reduces stress-induced gastric mucosal injury by inhibiting neutrophil activation in mice.
Zhao J; Harada N; Sobue K; Katsuya H; Okajima K
Growth Horm IGF Res; 2009 Apr; 19(2):136-45. PubMed ID: 18809348
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients.
Kihira T; Suzuki A; Kondo T; Wakayama I; Yoshida S; Hasegawa K; Garruto RM
Neuropathology; 2009 Oct; 29(5):548-58. PubMed ID: 19323791
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional up-regulation of cell surface Na V 1.7 sodium channels by insulin-like growth factor-1 via inhibition of glycogen synthase kinase-3β in adrenal chromaffin cells: enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion.
Yanagita T; Satoh S; Uezono Y; Matsuo K; Nemoto T; Maruta T; Yoshikawa N; Iwakiri T; Minami K; Murakami M
Neuropharmacology; 2011 Dec; 61(8):1265-74. PubMed ID: 21816165
[TBL] [Abstract][Full Text] [Related]
13. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
[TBL] [Abstract][Full Text] [Related]
14. IGF-1R/β-catenin signaling axis is involved in type 2 diabetic osteoporosis.
Zhang ZD; Ren H; Wang WX; Shen GY; Huang JJ; Zhan MQ; Tang JJ; Yu X; Zhang YZ; Liang D; Yang ZD; Jiang XB
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):838-848. PubMed ID: 31489803
[TBL] [Abstract][Full Text] [Related]
15. Catalase alleviates cardiomyocyte dysfunction in diabetes: role of Akt, Forkhead transcriptional factor and silent information regulator 2.
Turdi S; Li Q; Lopez FL; Ren J
Life Sci; 2007 Aug; 81(11):895-905. PubMed ID: 17765928
[TBL] [Abstract][Full Text] [Related]
16. Behavioral stress-induced activation of FoxO3a in the cerebral cortex of mice.
Zhou W; Chen L; Yang S; Li F; Li X
Biol Psychiatry; 2012 Apr; 71(7):583-92. PubMed ID: 21978520
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.
Sanz S; Pucilowska JB; Liu S; Rodríguez-Ortigosa CM; Lund PK; Brenner DA; Fuller CR; Simmons JG; Pardo A; Martínez-Chantar ML; Fagin JA; Prieto J
Gut; 2005 Jan; 54(1):134-41. PubMed ID: 15591519
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
19. Experimental approach to IGF-1 therapy in CCl
Morales-Garza LA; Puche JE; Aguirre GA; Muñoz Ú; García-Magariño M; De la Garza RG; Castilla-Cortazar I
J Transl Med; 2017 May; 15(1):96. PubMed ID: 28472963
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling.
Wang L; Yang HJ; Xia YY; Feng ZW
Apoptosis; 2010 Dec; 15(12):1470-9. PubMed ID: 20963499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
